Arkolith/Insider Trading/BDSI/Form 4

Smith Thomas B

Chief Medical OfficerBIODELIVERY SCIENCES INTERNATIONAL INC (BDSI) · full profile →Form 4 · filed Mar 22, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
1 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 22, 2022Other(J)53K—$00

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 22, 2022Disposed to issuer(D)287K—$00
Mar 22, 2022Disposed to issuer(D)259K—$00
Mar 22, 2022Disposed to issuer(D)89K—$00
Mar 22, 2022Disposed to issuer(D)118K—$00
Mar 22, 2022Disposed to issuer(D)130K—$00

Transaction Codes

J
Other acquisition / disposition
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001103021-22-000072) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML